Company: BGLC
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001477932-25-002725
Chunk: 202

Company: BioNexus Gene Lab Corp
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1
Chunk 202
---
,  December 31,   2024  2023 Investment in equity securities with readily determined fair value:      Malaysia  863,810   1,138,863 Singapore  177,808   79,577 Hong Kong  -   481,391   $1,041,618  $1,699,831 Investment in equity securities without readily determined fair value:        Malaysia  223,548   -   $1,265,166  $1,699,831  The Company’s investment in equity securities is measured at fair value on a recurring basis. These equity securities are classified as Level 1 in the fair value hierarchy, as the fair value is determined using quoted market prices in active markets for identical assets. Specifically, the stock prices of these securities are readily available on the stock exchange, providing a reliable and observable input to the fair value measurement. As these securities are actively traded, the quoted prices in the market are considered to be the most reliable indicator of fair value. No significant adjustments are made to these prices, as they reflect current market conditions at the measurement date.

 F-22Table of Contents

BIONEXUS GENE LAB CORP. 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 

FOR THE YEAR ENDED DECEMBER 31, 2024 AND 2023 

(Currency expressed in United States Dollars (“US$”)) 

(Audited)

NOTE 8 – TRADE PAYABLES Trade payables are amounts billed to the Company by suppliers for goods and services in the ordinary course of business. All amounts have short-term repayment terms and vary by supplier.

NOTE 9 – REVENUE  The following table shows disaggregated net revenue from contracts with customers by product or service line and geographic area for the year ended December 31, 2024 and 2023:     For the year ended    December 31,  December 31,   2024  2023 Revenue by product or service line:      Trading of industrial chemicals  9,494,577   9,746,587 Screening services and related sales  16,069   24,219  Net revenue  $9,510,646  $9,770,806          Revenue by geographic area        Bangladesh